|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-06-11 Purchase |
2009-06-15 3:47 pm | Urigen Pharmaceuticals, Inc. | UGRP.OB | Shmagin Martin E (Chief Financial Officer Director) | 1,500 | $0.08 | $120 | 3,138,573 (Direct) | View |
| 2009-03-16- -2009-03-18 Purchase |
2009-03-18 9:57 pm | Urigen Pharmaceuticals, Inc. | UGRP.OB | Shmagin Martin E (Chief Financial Officer Director) | 3,000 | $0.08667 | $260 | 3,137,073 (Direct) |
View |
| 2009-03-09- -2009-03-13 Purchase |
2009-03-13 6:28 pm |
Urigen Pharmaceuticals, Inc. | UGRP.OB | Shmagin Martin E (Chief Financial Officer Director) | 4,000 | $0.09 | $360 | 3,134,073 (Direct) |
View |
| 2009-03-05- -2009-03-06 Purchase |
2009-03-10 1:24 pm | Urigen Pharmaceuticals, Inc. | UGRP.OB | Shmagin Martin E (Chief Financial Officer Director) | 5,000 | $0.08 | $400 | 3,131,073 (Direct) |
View |
| 2009-02-24- -2009-02-25 Purchase | 2009-02-26 5:24 pm |
Urigen Pharmaceuticals, Inc. | UGRP.OB | Shmagin Martin E (Chief Financial Officer Director) | 3,500 | $0.1114 | $390 | 3,126,073 (Direct) | View |
| 2009-01-29 Purchase | 2009-02-03 3:12 pm | Urigen Pharmaceuticals, Inc. | UGRP.OB | Shmagin Martin E (Chief Financial Officer Director) | 4,000 | $0.1075 | $430 | 3,122,573 (Direct) |
View |
| 2009-01-27- -2009-01-28 Purchase |
2009-01-30 4:42 pm | Urigen Pharmaceuticals, Inc. | UGRP.OB | Shmagin Martin E (Chief Financial Officer Director) | 25,500 | $0.1084 | $2,765 | 3,118,573 (Direct) | View |
| 2009-01-22- -2009-01-23 Sale(C) | 2009-01-26 5:43 pm |
Urigen Pharmaceuticals, Inc. | UGRP.OB | Shmagin Martin E (Chief Financial Officer Director) | 40,000 | $0.1475 | $5,900 | 3,094,073 (Direct) | View |
| 2009-01-20 Purchase | 2009-01-21 10:35 am | Urigen Pharmaceuticals, Inc. | UGRP.OB | Shmagin Martin E (Chief Financial Officer Director) | 140,000 | $0.2139 | $29,950 | 3,054,073 (Direct Indirect) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 19:48:01 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |